Price range: $269, $369 to $469

( 5mg, 7 mg, 12.5mg vial)

Injectable Compounded Semaglutide is a GLP-1 agonist for weight loss and diabetes management. It activates GLP-1 receptors, slowing gastric emptying and suppressing appetite. This typically results in decreased hunger, improves insulin sensitivity, and aids weight loss, and reduces inflammation.

When used in conjunction with diet and exercise it can be an effective tool to assist in weight loss. Statistically it provides 15-17% weight loss overall.

There are No guarantees, lifestyle changes are necessary for any weight loss program. Consents are required.

Semaglutide

Tirzepatide

Price Range: $329, $429, $629

( 20mg, 34mg to 68 mg vial)

Injectable Compounded Tirzepatide a GLP-1/GIP receptor agonist used for weight loss.It activates GLP-1 receptors, slowing gastric emptying and suppressing appetite. Additionally it provides glycemic control, enhancing insulin secretion and reducing appetite via central nervous system regulation. It promotes weight loss, improves glucose metabolism, and reduces inflammation.

When used in conjunction with diet and exercise it is an effective tool to assist in weight loss. Statistically it provides 20% weight loss overall.

There is no guarantee, lifestyle changes are necessary for any weight loss program. Consents are required.

Compounded :Phentermine

Buproprion/Naltrexone

Used alone ( no GLP1 perscribed) $110/month

Phentermine and bupropion/naltrexone are FDA-approved oral medications that can help with appetite suppression and weight management. On average, patients may lose about 5–10% of their body weight with these treatments. When combined with a GLP-1 medication such as semaglutide or tirzepatide, they can provide an added boost, working together to improve appetite control, reduce cravings, and support long-term weight loss success.